100% Quality Guarantee
PhD-Level Technical Support
Key Features

Recombinant TFF1/pS2 Monoclonal Antibody (AGEL6818)

SKU AGEL6818
Product Type Antibody
Reactivity Human
Applications WB, IHC
Host Species Rabbit
Clonality Monoclonal
Clone C321513
Conjugate Unconjugated
$606 - $843

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

Recombinant TFF1/pS2 Monoclonal Antibody

The Recombinant TFF1/pS2 Monoclonal Antibody is a recombinant rabbit monoclonal antibody (clone C321513) against TFF1/pS2. TFF1/pS2 is a gastric peptide that is highly expressed by mucosal goblet cells of the stomach, where it is thought to play a role in maintaining the integrity of the epithelial layer of the mucosa through the regulation of cell-cell adhesion and cell migration. Research studies have shown that TFF1 functions as a tumor suppressor in the stomach as its expression is frequently lost in gastric carcinomas, largely due to promoter hypermethylation. Research studies have also demonstrated that TFF1 is a transcriptional target of estrogen receptor-α and that TFF1 expression in breast carcinoma may be used as a predictive biomarker for response to anti-estrogen therapy. Produced by recombinant technology in Rabbit hosts and purified by Protein A affinity chromatography, this Rabbit IgG antibody is reactive against Human samples.

This antibody is suitable for WB and IHC applications. It has been validated by WB analysis of MDA-MB-231(Negative control), MCF-7 and IHC analysis of Human colon cancer, Human stomach. The target is localized to the secreted.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose